Galderma Group AG (GALDY)

OTCMKTS · Delayed Price · Currency is USD
31.48
+0.86 (2.81%)
Jul 8, 2025, 4:00 PM EDT
94.55%
Market Cap 37.08B
Revenue (ttm) 4.44B
Net Income (ttm) 231.00M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 160.51
Forward PE 52.59
Dividend 0.02 (0.08%)
Ex-Dividend Date Apr 28, 2025
Volume 11,868
Average Volume 4,448
Open 31.77
Previous Close 30.62
Day's Range 30.98 - 31.77
52-Week Range 15.51 - 31.48
Beta n/a
RSI 71.86
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GALDY
Full Company Profile

Financial Performance

Financial Statements

News

Galderma Announces Departure of Its Chief Financial Officer

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company t...

8 days ago - Business Wire

Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of ...

14 days ago - Business Wire

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Strategic move aims to accelerate innovation and growth in the U.S., Galderma's largest region MIAMI , June 17, 2025 /PRNewswire/ -- Galderma (SIX: GALD), the pure-play dermatology category leader, to...

21 days ago - PRNewsWire